BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 11393533)

  • 1. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
    Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
    J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.
    Deguchi M; Yoshida S; Kennedy S; Ohara N; Motoyama S; Maruo T
    J Soc Gynecol Investig; 2005 Apr; 12(3):208-13. PubMed ID: 15784508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
    Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY
    BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M; Ghosh S; Roy B
    Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
    Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
    Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
    Leggett CS; Doll MA; States JC; Hein DW
    Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
    Hernández-González O; Ortiz-Zamudio JJ; Rodríguez-Pinal CJ; Alvarado-Morales I; Martínez-Jiménez VDC; Salazar-González RA; Correa-González LC; Gómez R; Portales-Pérez DP; Milán-Segovia RDC
    Leuk Lymphoma; 2018 Aug; 59(8):1968-1975. PubMed ID: 29214875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
    Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
    Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
    Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
    Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.